Journal Content

ONCOLOGY Latest Issue

More from this issue  |   Archives  |  Subscribe  |   Publication Services

ASCO 2010 – Focus on Breast Cancer
ONCOLOGY,  July 22, 2010





ASCO

ANNUAL MEETING 2010

 

Our on-site coverage of the annual meeting: Five internationally regarded oncologists give exclusive interviews and expert perspective reports of the highlights of this year’s meeting...

ASCO Gastrointestinal Cancers
GI cancer experts Richard M. Goldberg, MD, and Peter C. Enzinger, MD: Clinical investigators share their insight into the best GI sessions and practice-changing trends.

ASCO Renal Cell Carcinoma
Andrew J. Armstrong, MD, MSc, and Robert J. Motzer, MD: Learn about the paradigm-shifting advent of targeted therapies; find out what’s down the pike in RCC.

ASCO Hematologic Cancers
Samuel M. Silver, MD, PhD: an internationally recognized hematologist shares insight into the future of blood cancer treatment and research, selecting the most relevant content for ASCO 2010.

 

 

Plus the hottest ASCO news on Breast Cancer, from the CancerNetwork's reporters!

 

ASCO 2010 Focus on Breast Cancer

 

 

Cancer Management Handbook,
12th Edition

 

A Ready Reference to the Multidisciplinary Diagnosis and Treatment of:

Breast cancer
Lung cancer
Gastrointestinal cancer
Skin cancer
Leukemia
Other malignancies
Complete Contents »

 

Purchase the Cancer Management Handbook 12th Edition Today

 

Oncology NEWS INTERNATIONAL

More from this issue  |   Archives  |  Subscribe  |   Publication Services

Some ovarian tumors can be safely followed on ultrasound
Oncology NEWS International,  July 14, 2010

Help us ensure that we are covering the news and views that you want to read. Take our brief survey and assist us in developing coverage for future issues of Oncology NEWS International.

Click here access the survey.

Click here to enter your name in our raffle for a chance to win a $200 Visa gift card!

PRACTICE & POLICY

ACCC releases findings of “Cancer Care Trends in Community Cancer Centers” survey
Ron Piana , July 28, 2010

This year’s “Cancer Trends” survey provides insight into ambulatory cancer care, effects of the recession, and organizational strategies that may help providers adapt to the changes in the healthcare marketplace.

CMS vs the Compassionate Access Act
Frank Burroughs, Founder and President of the Abigail Alliance , July 28, 2010

Medicare is now questioning whether the government should pay for new therapy's such as Provenge. The CMS decision is just as important to the biopharmaceutical industry, doctors, and their patients as it is to Dendreon. H. R. 4732, The Compassionate Access Act, calls to give access to novel drugs;will CMS serve as a roadblock?

Abigail Alliance responds to New York Times editorial on FDA’s Avastin Decision
Ron Piana , July 26, 2010

This is decision time at FDA. Since the agency gave accelerated approval for Avastin in first-line treatment of metastatic breast, two follow-up studies “failed to confirm the magnitude” of the benefits seen in that first study of Avastin. Consequently, ODAC voted 12 to 1, urging FDA to reverse its approval of Avastin in this indication.

EMRs are the future: What is "Meaningful Use"?
Ron Piana , July 23, 2010

Most busy oncologists will never have time or patience to sift through the 864-page final rule CMS released Tuesday describing how health care providers can demonstrate "meaningful use" of electronic health records to qualify for Medicare and Medicaid incentive payments under the 2009 federal stimulus package.

Mortality results from the Göteborg prostate-cancer screening trial
Ron Piana , July 20, 2010

Prostate cancer is one of the leading causes of death from malignant disease among men in the developed world. The extent of benefit and harm with widespread PSA screening is under continuous debate.


Energy Therapies
ONCOLOGY Nurse Edition,  July 9, 2010
Quality Care Depends on Knowledge and Action
ONCOLOGY Nurse Edition,  July 9, 2010

CME Center

E-Learning | E-TextbooksWebcasts

CancerNetwork.com offers a variety of Continuing Medical Education (CME) programs based on ONCOLOGY review articles, supplements to ONCOLOGY and Oncology News International, textbooks, roundtable discussions, e-learning programs and webcasts. CME These interactive CME activities are offered to physicians and other healthcare professionals without charge by CME.

CME LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Click here to see a list of CME activities.
CME Content

Integrating Genetics and Genomics Into Oncology Nursing
March 1, 2010
By Dale Halsey Lea, MPH, RN, CGC, FAAN
Health Educator, National Human Genome Research Institute


This activity is based on articles and reports in ONCOLOGY Nurse Edition. It is developed from an identified educational need for information about practical management issues in medical, surgical, and radiation oncology. This activity has been developed and approved under the direction of CME LLC.
 

CME, 1.0 Credits
Hosted on cmellc.com

Most Popular Articles

From the CN Newsroom...

Nanoparticles reveal then kill cancers…maybe
Oncology NEWS Today Blog,  July 27, 2010

Miami Breast Cancer Conference

In our exclusive on-site coverage of this event, ONCOLOGY has engaged nationally recognized breast cancer specialist Harold J. Burstein, MD, PhD, Associate Professor of Medicine, Harvard Medical School to provide insight on the meeting’s most clinically relevant sessions.

 

Our coverage will also include expert perspectives, abstract/poster reviews, and interviews and podcasts with other leaders in the field.

 

Monitoring Response in CML Treatment

  

Join Dr. Richard Stone of Dana-Farber and CML patient Robert Roy in this new podcast that explores the physician-patient perspective and treatment goals.

 

Risk Assessment in Stage II Colon Cancer
ONCOLOGY, January 2010
 

CME LLC's Highlights in Breast Cancer Treatment From the ASCO® 2009 Annual Meeting

CME LLC's Highlights in Breast Cancer Treatment From the ASCO® 2009 Annual Meeting

 

 

Update #1

 

Update 1: Concept of Maintenance
Chemotherapy in NSCLC

Update 2: MSI - To Test or Not To Test

Update 3: MSI - The Role of Cetuximab in NSCLC
(Lancet-flex Study)

Update 4: New Studies in GI Cancer

Update 5: Patient Selection for Adjuvant Therapy

 

Tumor Board Events
On-Demand

In Streaming Video

 

Learn from thought leaders through interactive webcast discussions, designed to help you navigate treatment challenges in oncology.

 

New Perspectives in Metastatic Breast Cancer 2009
An Online Tumor Board Event
A Seidman

Hosted by:
Program Chair: Andrew D. Seidman, MD,
Professor of Medicine, Weill Medical College of Cornell University Attending Physician, Memorial Sloan-Kettering Cancer Center New York, NY

Renal Cell Carcinoma
An On-Demand Tumor Board Event

Hosted by:
Program Chair: Ronald M. Bukowski, MD,
Emeritus Staff, CCF Taussing Cancer Center Proffessor of Medicine, CCF Lerner College of Medicine of CWRU, Case Western


Chronic Myelogenous Leukemia
An On-Demand Tumor Board Event

Hosted by:
Program Chair: Charles A. Schiffer, MD,
Director, Multidisciplinary Leukemia Lymphoma Medical Oncology, Wayne State University School of Medicine, Detroit